Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$33.11
-2.10%
Mkt Cap $25.18B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (28 analysts)
$37.17
Range $30.00 – $42.00
Implied Upside
+12.3%
Consensus $37.17 vs current $33.11
NASDAQ·Healthcare·Biotechnology
$33.11
-2.10%
Mkt Cap $25.18B
Buy
9
Hold
0
Sell
0
Price Target (28 analysts)
$37.17
Range $30.00 – $42.00
+12.3%
Consensus $37.17 vs current $33.11